New mapping tech aims to stop AFib in its tracks
NCT ID NCT07358611
First seen Jun 25, 2026 · Last updated Jul 09, 2026 · Updated 3 times
Summary
This pilot study tests whether using a noninvasive global mapping system to guide catheter ablation can improve outcomes for people with persistent atrial fibrillation. Thirty participants will receive standard pulmonary vein isolation plus personalized ablation of up to three additional heart regions identified by the mapping system. Researchers will track how often the heart returns to normal rhythm during the procedure and how many patients remain free of arrhythmia for a year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- catheter ablation guided by noninvasive global mapping
- What this could lead to
- If successful, this personalized ablation approach could reduce the chance of atrial fibrillation coming back after treatment.
- What could go wrong
- This is a small pilot study with only 30 participants, so results may not apply to everyone. The procedure carries standard risks of catheter ablation, such as bleeding or heart rhythm issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Clinic, University of Barcelona
RECRUITINGBarcelona, 08036, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a smartphone alert replace daily blood thinners for AF?
- Blood fat clues could flag hidden heart rhythm risk
- Can a new heart ablation technique work without x-rays?
- Which blood thinner is safer for heart patients? a Head-to-Head test
- Smartphone light sensor may spot when an irregular heartbeat fixes itself
- Can a cholesterol drug keep atrial fibrillation at bay after ablation?